Q2 2023 13F Holders as of 6/30/2023
-
Type / Class
-
Equity / COM
-
Number of holders
-
37
-
Total 13F shares, excl. options
-
1.25M
-
Shares change
-
+769K
-
Total reported value, excl. options
-
$20M
-
Value change
-
+$12.4M
-
Number of buys
-
35
-
Number of sells
-
-5
-
Price
-
$15.97
Significant Holders of Nuvectis Pharma, Inc. - COM (NVCT) as of Q2 2023
40 filings reported holding NVCT - Nuvectis Pharma, Inc. - COM as of Q2 2023.
Nuvectis Pharma, Inc. - COM (NVCT) has 37 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1.25M shares
.
Largest 10 shareholders include BlackRock Inc. (314K shares), VANGUARD GROUP INC (266K shares), GEODE CAPITAL MANAGEMENT, LLC (113K shares), STATE STREET CORP (105K shares), BALDWIN BROTHERS LLC/MA (90.1K shares), FORBES J M & CO LLP (67K shares), NORTHERN TRUST CORP (53.6K shares), MARSHALL WACE, LLP (41.8K shares), RENAISSANCE TECHNOLOGIES LLC (36.4K shares), and CITADEL ADVISORS LLC (28K shares).
This table shows the top 37 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.